Private credit risk gauges are climbing at the margin, but the asset class remains structurally isolated from the broader financial system, limiting immediate spillover concerns. Portfolio leverage among direct lenders rose 14% year-over-year in Q4 2024, while non-accrual rates inched up 90 basis points to 2.3% across the surveyed universe. The risk is real, the containment is real, and the question is whether both can remain true simultaneously.
The elevation comes from predictable sources. Software portfolio companies — the darlings of the 2020-2022 vintage — are accounting for a disproportionate share of recent write-downs, with several lenders marking middle-market SaaS names down 15% to 25% in the past six months. Leverage multiples on new deals remain elevated at 5.8x EBITDA, down only marginally from the 6.1x peak in mid-2023. Covenant-lite structures still dominate 78% of new issuance. The risk stack is taller, the margin for error is thinner, and the exits are narrower than they were eighteen months ago.
What matters is the firebreak. Private credit sits outside the public debt markets, outside the securitization engine, and — critically — outside the daily liquidity demands that amplify stress in traditional credit vehicles. $1.7 trillion in assets under management sounds large until you remember that U.S. corporate bond markets total $10.5 trillion, and that private credit funds lock up capital for seven to ten years. The contagion pathways are narrow: pension funds and insurance companies hold stakes, but those positions are marked quarterly at best, often annually, and almost never trigger forced selling. The violence, if it comes, will be slow and private.
The soft spots are appearing anyway. Fundraising for U.S.-focused direct lending vehicles fell 22% in 2024 versus 2023, even as Ares and Apollo push deeper into Asia and Europe. Redemption requests at interval funds — the quasi-liquid private credit vehicles marketed to retail — ticked up 40 basis points sequentially in Q4. Software names aren't the only problem; healthcare services and business services portfolios are showing stress in companies levered above 6x that haven't hit their growth targets. The denominator effect is starting to bite: allocators who overshot their private markets exposure in 2021-2022 are now underweight public equities and looking for rebalancing opportunities, not new commitments.
Operators and allocators should watch three specific developments over the next six months. First, Q1 2025 non-accrual rates, reported in mid-April, will show whether the 2.3% figure was a temporary spike or the start of a trend; anything above 3% changes the conversation. Second, the pace of software company refinancings in the $200 million to $500 million range — several are expected in May and June — will test whether there's real bid for stressed middle-market tech assets or just more extend-and-pretend. Third, interval fund redemption data in the April-June window will clarify whether retail investors are truly exiting or just adjusting at the margin.
The asset class has built its moat. The question is whether the moat is drainage or defense.